Your email has been successfully added to our mailing list.

×
-0.0124052377670572 -0.0124052377670572 -0.0124052377670572 -0.0124052377670572 -0.011722949689869 -0.011722949689869 -0.0137835975189524 -0.0148862853204686
Stock impact report

LEO Pharma Presents Late-Breaking Anzupgo® (delgocitinib) Cream Presentation at EADV 2024 Highlighting Results of Head-to-Head DELTA FORCE Trial in Chronic Hand Eczema (CHE) [Yahoo! Financ...

JAPAN TOBACCO UNSP/ADR (JAPAY) 
NASDAQ:AMEX Investor Relations: gungho.co.jp/en/ir
Company Research Source: Yahoo! Finance
with delgocitinib cream had a significantly higher efficacy compared to oral alitretinoin capsules among adult patients with severe CHE. Six other pieces of investigational delgocitinib cream research form part of LEO Pharma's extensive scientific program at EADV 2024. Remaining abstracts include post hoc BALLERUP, Denmark, September 25, 2024 BUSINESS WIRE NOT FOR UK USE – NOT INTENDED FOR UK MEDIA ® (delgocitinib) cream as a potential treatment for adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. The findings for delgocitinib cream have been delivered as part of one of LEO Pharma's most extensive scientific programs to date at the 33 rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam. Alongside delgocitinib cream, alitretinoin is the only other treatment currently approved in the European Union to specifically treat severe CHE in patients who do not respond to t Show less Read more
Impact Snapshot
Event Time:
JAPAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for JAPAY alerts
Opt-in for
JAPAY alerts

from News Quantified
Opt-in for
JAPAY alerts

from News Quantified